Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jost

Showing results (31-40 of 202) with videos related to

Pageof 21
Sort By:
Cell Death and Differentiation|October 1, 2011
Fas death receptor signalling: roles of Bid and XIAPT Kaufmann, A Strasser, P J Jost
Immunity|February 26, 2009
The many roles of FAS receptor signaling in the immune systemAndreas Strasser, Philipp J Jost, Shigekazu Nagata
Der Internist|March 13, 2019
[Kinase inhibitors in oncology : What is new?]K Riedmann, F Bassermann, P J Jost
Schweizerische Medizinische Wochenschrift|February 25, 1989
[Clinical counseling and management of HIV-positive patients--secondary individual prophylaxis in patients with HIV infection]R Weber, A Bonetti, J Jost, et al.
The American Journal of Physiology|October 1, 1994
Plasma and platelet catecholamine and catecholamine sulfate response to various exercise testsG Strobel, B Friedmann, J Jost, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 1, 1980
[Diabetic retinitis in children and adolescents and its relationship to regulation (author's transl)]K Hoffmann, K Gilde, P Hürter, et al.
BMC Nephrology|May 5, 2018
Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograftPhilipp Moog, Philipp J Jost, Maike Büttner-Herold
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 28, 2009
Complexity measures from interaction structuresT Kahle, E Olbrich, J Jost, et al.
Der Internist|September 1, 1990
[HIV-associated opportunistic diseases: diagnostic and therapeutic possibilities in the clinic and general practice]R Weber, J Jost, R Lüthy, et al.
Schweizerische Medizinische Wochenschrift|February 13, 1988
[HIV-associated thrombocytopenia]J Jost, M G Täuber, R Lüthy, et al.
Pageof 21

Showing results (31-40 of 202) with videos related to

Sort By:
Pageof 21
Cell Death and Differentiation|October 1, 2011
Fas death receptor signalling: roles of Bid and XIAPT Kaufmann, A Strasser, P J Jost
Immunity|February 26, 2009
The many roles of FAS receptor signaling in the immune systemAndreas Strasser, Philipp J Jost, Shigekazu Nagata
Der Internist|March 13, 2019
[Kinase inhibitors in oncology : What is new?]K Riedmann, F Bassermann, P J Jost
Schweizerische Medizinische Wochenschrift|February 25, 1989
[Clinical counseling and management of HIV-positive patients--secondary individual prophylaxis in patients with HIV infection]R Weber, A Bonetti, J Jost, et al.
The American Journal of Physiology|October 1, 1994
Plasma and platelet catecholamine and catecholamine sulfate response to various exercise testsG Strobel, B Friedmann, J Jost, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 1, 1980
[Diabetic retinitis in children and adolescents and its relationship to regulation (author's transl)]K Hoffmann, K Gilde, P Hürter, et al.
BMC Nephrology|May 5, 2018
Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograftPhilipp Moog, Philipp J Jost, Maike Büttner-Herold
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 28, 2009
Complexity measures from interaction structuresT Kahle, E Olbrich, J Jost, et al.
Der Internist|September 1, 1990
[HIV-associated opportunistic diseases: diagnostic and therapeutic possibilities in the clinic and general practice]R Weber, J Jost, R Lüthy, et al.
Schweizerische Medizinische Wochenschrift|February 13, 1988
[HIV-associated thrombocytopenia]J Jost, M G Täuber, R Lüthy, et al.
Pageof 21